A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(14 sites)
United States
Stanford University Medical Center CTRU - 800 Welch Road- Site Number : 8400021, Palo Alto, California Mission Dermatology Center- Site Number : 8400011, Rancho Santa Margarita, California Pediatric Center of Excellence (PCE) - Miami Pediatric Endocrinology- Site Number : 8400005, Coral Gables, Florida Life Clinical Trials - Coral Springs- Site Number : 8400018, Coral Springs, Florida Direct Helpers Research Center- Site Number : 8400015, Hialeah, Florida SunCoast Skin Solutions - Lutz- Site Number : 8400008, Lutz, Florida USF Health- Site Number : 8400003, Tampa, Florida Tareen Dermatology - Eagan- Site Number : 8400022, Eagan, Minnesota MediSearch Clinical Trials- Site Number : 8400004, Saint Joseph, Missouri AXIS Clinicals - Fargo- Site Number : 8400013, Fargo, North Dakota Vital Prospects Clinical Research Institute - Tulsa- Site Number : 8400002, Tulsa, Oklahoma Dell Children's Medical Center- Site Number : 8400007, Austin, Texas Driscoll Children's Hospital- Site Number : 8400017, Corpus Christi, Texas Texas Dermatology and Laser Specialists - San Antonio - Oakwell Court- Site Number : 8400020, San Antonio, Texas Last updated January 2026